Skip to main content
Top
Published in: World Journal of Urology 7/2019

01-07-2019 | Prostate Cancer | Editorial

From indecision to precision: advances in imaging in metastatic prostate cancer

Authors: D. Bolton, M. Frydenberg

Published in: World Journal of Urology | Issue 7/2019

Login to get access

Excerpt

There can be little doubt that advances in medical imaging have had the greatest influence on prostate cancer management, since the identification of PSA and its use as the dominant serum biomarker for prostate cancer. Currently available imaging formats using MRI and PET technology have become incorporated into the treatment algorithm for prostate cancer in a manner that could not have been conceived in the early phase of this current era of prostate cancer treatment. …
Literature
2.
go back to reference Pokorny M, Kua B, Esler R, Yaxley J, Samaratunga H, Dunglison N, Gianduzzo T, Coughlin G, Holt R, Laing B, Ault D, Brown N, Parkinson R, Thompson L (2018) MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature. World J Urol. https://doi.org/10.1007/s00345-018-2497-y CrossRefPubMed Pokorny M, Kua B, Esler R, Yaxley J, Samaratunga H, Dunglison N, Gianduzzo T, Coughlin G, Holt R, Laing B, Ault D, Brown N, Parkinson R, Thompson L (2018) MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature. World J Urol. https://​doi.​org/​10.​1007/​s00345-018-2497-y CrossRefPubMed
Metadata
Title
From indecision to precision: advances in imaging in metastatic prostate cancer
Authors
D. Bolton
M. Frydenberg
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 7/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02820-9

Other articles of this Issue 7/2019

World Journal of Urology 7/2019 Go to the issue